The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging

Chini, Eduardo N., Chini, Claudia C.S., Espindola Netto, Jair Machado, de Oliveira, Guilherme C., van Schooten, Wim·2018·Trends in Pharmacological Sciences

DOI 10.1016/j.tips.2018.02.001

Cited by (226)

Items 101–200 of 226

Anti-cancer activity of Biochanin A against multiple myeloma by targeting the CD38 and cancer stem-like cells
Vinod Kumar Jaina, Abhisheik Eedara, Sasi Priya SVS, Surender Singh Jadav, Sabarinadh Chilaka, Ramakrishna Sistla, Sai Balaji Andugulapati · 2022 · Process Biochemistry
Identifying the Role of Oxidative Stress‐Related Genes as Prognostic Biomarkers and Predicting the Response of Immunotherapy and Chemotherapy in Ovarian Cancer
Qingyang Liu, Xiaocheng Yang, Yuhan Yin, Hao Zhang, Fanxing Yin, Panpan Guo, Xiaoxu Zhang, Chenxi Sun, Shining Li, Yanshuo Han et al. · 2022 · Oxidative Medicine and Cellular Longevity
CD38 Deficiency Alleviates Diabetic Cardiomyopathy by Coordinately Inhibiting Pyroptosis and Apoptosis
Ling-Fang Wang, Qian Li, Ke Wen, Qi‐Hang Zhao, Yating Zhang, Jia-Le Zhao, Qi Ding, Xiao‐Hui Guan, Yun‐Fei Xiao, Ke‐Yu Deng et al. · 2023 · International Journal of Molecular Sciences
Designing in vitro Blood-Brain Barrier Models Reproducing Alterations in Brain Aging
Elena D. Osipova, Yulia K. Komleva, Andrey V. Morgun, Olga L. Lopatina, Yu. A. Panina, Raissa Ya. Olovyannikova, E. F. Vais, Vladimir V. Salmin, Alla B. Salmina · 2018 · Frontiers in Aging Neuroscience
Codonopsis pilosula Polysaccharides Alleviate Aβ1-40-Induced PC12 Cells Energy Dysmetabolism via CD38/NAD+ Signaling Pathway
Yi R. Hu, San L. Xing, Chuan Chen, Ding Z. Shen, Jiu L. Chen · 2021 · Current Alzheimer Research
CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
Antoine de Zélicourt, Abdallah Fayssoil, Mbarka Dakouane‐Giudicelli, Isley de Jesus, Ahmed Karoui, Faouzi Zarrouki, Florence Lefebvre, Arnaud Mansart, Jean‐Marie Launay, Jérôme Piquereau et al. · 2022 · EMBO Molecular Medicine
Emerging roles of ADP-ribosyl-acceptor hydrolases (ARHs) in tumorigenesis and cell death pathways
Xiangning Bu, Jiro Kato, Joel Moss · 2018 · Biochemical Pharmacology
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
Peter Bannas, Friedrich Koch‐Nolte · 2018 · Frontiers in Immunology
Targeting Epigenetic Mechanisms in Vascular Aging
Zhongxiao Lin, Qian Ding, Xinzhi Li, Yuliang Feng, Hao He, Chuoji Huang, Yi Zhun Zhu · 2022 · Frontiers in Cardiovascular Medicine
Distinct physical condition and social behavior phenotypes of CD157 and CD38 knockout mice during aging
Maria Gerasimenko, Olga L. Lopatina, Anna A. Shabalova, Черепанов Станислав Михайлович, Alla B. Salmina, Shigeru Yokoyama, Hisanori Goto, Hiroshi Okamoto, Yasuhiko Yamamoto, Katsuhiko Ishihara et al. · 2020 · PLoS ONE
ZDHHC9-mediated CD38 palmitoylation stabilizes CD38 expression and promotes pancreatic cancer growth
Hui Guo, Zhiqing Lin, Di Zhang, Qilong Qin, Zewen Li, Yuqing Yin, Jiang‐Fan Chen, Wei Mei Guo · 2025 · Communications Biology
Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective
Yu Fan, Huiying Zhao, Luo Lu, Wei Wu · 2025 · Nutrients
NAD+: An old but promising therapeutic agent for skeletal muscle ageing
Yingying Xu, Weihua Xiao · 2023 · Ageing Research Reviews
Roles of NAD+ and Its Metabolites Regulated Calcium Channels in Cancer
Peilin Yu, Xiaobo Cai, Yan Liang, Mingxiang Wang, Wei Yang · 2020 · Molecules
Novel Approach to Skin Anti-Aging: Boosting Pharmacological Effects of Exogenous Nicotinamide Adenine Dinucleotide (NAD+) by Synergistic Inhibition of CD38 Expression
Seongsu Kang, Ji-Won Park, Zhihong Cheng, Sanghyun Ye, Seung‐Hyun Jun, Nae Gyu Kang · 2024 · Cells
Daratumumab and Nanobody-Based Heavy Chain Antibodies Inhibit the ADPR Cyclase but not the NAD+ Hydrolase Activity of CD38-Expressing Multiple Myeloma Cells
Natalie Baum, Ralf Fliegert, Andreas Bauche, Julia Hambach, Stephan Menzel, Friedrich Haag, Peter Bannas, Friedrich Koch‐Nolte · 2020 · Cancers
Modulation of aryl hydrocarbon receptor (AHR) and the NAD+-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)
Karl Walter Bock · 2020 · Biochemical Pharmacology
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
Ondřej Lidický, Pavel Klener, Daniela Machová, Petra Vočková, Eva Pokorná, Karel Helman, Cory K. Mavis, Olga Janoušková, Tomáš Etrych · 2020 · Journal of Controlled Release
Nicotinic acid riboside maintains NAD+ homeostasis and ameliorates aging-associated NAD+ decline
Won-Suk Song, Xiyu Shen, Kang Du, Cuauhtemoc B. Ramirez, Sang Hee Park, Yang Cao, Johnny Le, Hosung Bae, Joo‐Hwan Kim, Yujin Chun et al. · 2025 · Cell Metabolism
Comprehensive Proteomics Analysis Identifies CD38-Mediated NAD+ Decline Orchestrating Renal Fibrosis in Pediatric Patients With Obstructive Nephropathy
Yuandong Tao, Jifeng Wang, Xuexue Lyu, Na Li, Dong Lai, Yuanyuan Liu, Xingyue Zhang, Pin Li, Shouqing Cao, Xiaoguang Zhou et al. · 2023 · Molecular & Cellular Proteomics
Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells
Xinyi Zhou, Dongliang Fu, Hang Sheng Yang, Chenqin Le, Yier Lu, Jingsun Wei, Yang Tang, Jiawei Zhang, Ying Yuan, Kefeng Ding et al. · 2023 · Cancer Letters
Conceptual Framework for SARS-CoV-2–Related Lymphopenia
Ilnaz Rahimmanesh, Shirin Kouhpayeh, Yadollah Azizi, Hossein Khanahmad · 2022 · Advanced Biomedical Research
Anti‐CD38 monoclonal antibody interference with blood compatibility testing: Differentiating isatuximab and daratumumab via functional epitope mapping
Btissam Chami, Makoto Okuda, Morvarid Moayeri, France Pirenne, Yoko Hidaka, Ashok Nambiar, Zhili Song, Olivier Bedel, Bailin Zhang, Joern Hopke et al. · 2022 · Transfusion
Fingerstick blood assay maps real‐world NAD + disparity across gender and age
Pei Wang, Meiting Chen, Yaying Hou, Jun Luan, Ruili Liu, Liuqing Chen, Min Hu, Qiuliyang Yu · 2023 · Aging Cell
Pyridine Nucleotide Metabolites and Calcium Release from Intracellular Stores
Antony Galione, Kai‐Ting Chuang · 2019 · Advances in experimental medicine and biology
Mitochondrial dysfunction drives cellular senescence: Molecular mechanisms of inter-organelle communication
Ziyue Xie, Xinyu Zhang, Yu Li, Ruigong Zhu · 2025 · Experimental Gerontology
89Zr-DFO-Isatuximab for CD38-Targeted ImmunoPET Imaging of Multiple Myeloma and Lymphomas
Natalia Herrero Álvarez, Alexa L. Michel, Tara D. Viray, Marius Erik Mayerhoefer, Jason Stuart Lewis · 2023 · ACS Omega
Codonopsis pilosula Polysaccharides Alleviate Aβ1-40-Induced PC12 Cells Energy Dysmetabolism via CD38/NAD+ Signaling Pathway
2021 · Current Alzheimer Research
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38 + pro-inflammatory macrophages
2019
CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai · 2021 · Biochemical and Biophysical Research Communications
Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation
Thomas Zachary Benton, Catherine M. Mills, Jonathan M. Turner, Megan J. Francis, Dalan J. Solomon, Pieter B. Burger, Yuri Karl Peterson, Nathan G. Dolloff, André S. Bachmann, Patrick M. Woster · 2021 · RSC Advances
A Molecular Perspective and Role of NAD+ in Ovarian Aging
Mehboob Ahmed, Umair Riaz, Haimiao Lv, Liguo Yang · 2024 · International Journal of Molecular Sciences
Exploring nicotinamide adenine dinucleotide precursors across biosynthesis pathways: Unraveling their role in the ovary
Caifang Ren, Zhang Shuang, Yanyan Chen, Kaiping Deng, Meiqian Kuang, Zihao Gong, Ke Zhang, Panqi Wang, Pan Huang, Zhengrong Zhou et al. · 2024 · The FASEB Journal
Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury
Qi‐Hang Zhao, Yating Zhang, Ke Wen, Qi Ding, Ziying Chen, Dilinuer Tula, Jia-Hui Li, Juan Zhou, Yun‐Fei Xiao, Xiao‐Hui Guan et al. · 2025 · Signal Transduction and Targeted Therapy
Brain Proteome Profiling Reveals Common and Divergent Signatures in Parkinson’s Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
Fiona Dick, Gard Aasmund Skulstad Johanson, Ole‐Bjørn Tysnes, Guido Werner Alves, Christian Dölle, Charalampos Tzoulis · 2024 · Molecular Neurobiology
Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs
Bo Shi, Asif Amin, Pranjali Dalvi, Wenxia Wang, Nicholas W. Lukacs, Li Kai, Paul Cheresh, Thais Peclat, Claudia C.S. Chini, Eduardo N. Chini et al. · 2023 · Scientific Reports
Development of a machine learning-based predictive risk model combining fatty acid metabolism and ferroptosis for immunotherapy response and prognosis in prostate cancer
Zepeng Wang, Zhihong Dai, Yuren Gao, Zhongxiang Zhao, Zhen Li, Liang Wang, Xiang Gao, Qiuqiu Qiu, Xiaofu Qiu, Zhiyu Liu · 2025 · Discover Oncology
A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways
Aoyu Fan, Yunyan Zhang, Jiangting Cheng, Yunpeng Li, Wei Chen · 2022 · Frontiers in Oncology
Evolutionary Views of Tuberculosis: Indoleamine 2,3‐Dioxygenase Catalyzed Nicotinamide Synthesis Reflects Shifts in Macrophage Metabolism
Melinda Shelley Suchard, Clement Gascua Adu-Gyamfi, Bridgette M. Cumming, Dana M. Savulescu · 2020 · BioEssays
Nicotinamide and Pyridoxine in Muscle Aging: Nutritional Regulation of Redox, Inflammation, and Regeneration
Agnieszka Nowacka, Maciej Śniegocki, Martyna Śniegocka, Ewa Ziółkowska · 2025 · Antioxidants
The known unknowns of mitochondrial carcinogenesis:de novoNUMTs and intercellular mitochondrial transfer
Tigran A. Harutyunyan · 2023 · Mutagenesis
The role of NAD+ metabolism in macrophages in age-related macular degeneration
Ruoyi Lin, Jing Yu · 2022 · Mechanisms of Ageing and Development
Role of CD38 in Adipose Tissue: Tuning Coenzyme Availability?
Andrea Benzi, Alessia Grozio, Sonia Spinelli, Laura Sturla, Andreas H. Guse, Antonio DE FLORA, Elena Zocchi, Jöerg Heeren, Santina Bruzzone · 2021 · Nutrients
Nicotinamide N-Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets
Shi-Yan Lai, Xiaojuan Zhu, Wei-Dong Sun, Shuang-Zhou Bi, Chen-Ying Zhang, An Liu, Jiang-Hua Li · 2025 · Biomolecules
Cell Type–Specific Roles of CD38 in the Interactions of Isoniazid with NAD+ in the Liver
Junjie Zhu, Jie Li Lu, Hung‐Chun Tung, Ke Liu, Jianhua Li, Denis M. Grant, Wen Xie, Xiaochao Ma · 2020 · Drug Metabolism and Disposition
Of Mice and Men: NAD+ Boosting with Niacin Provides Hope for Mitochondrial Myopathy Patients
Eduardo N. Chini · 2020 · Cell Metabolism
Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
Knut Husø Lauritzen, Kuan Yang, Michael Frisk, Mieke C. Louwe, Maria Belland Olsen, Mathias Ziegler, William Edward Louch, Bente Lise Halvorsen, Pål Aukrust, Arne Yndestad et al. · 2025 · Frontiers in Immunology
NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction
Amanda J. Stock, Yie Liu · 2021 · Frontiers in Aging
Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes
Cecilia Astigiano, Andrea Benzi, Maria Elena Laugieri, Francesco Piacente, Laura Sturla, Lucrezia Guida, Santina Bruzzone, Antonio DE FLORA · 2022 · Cells
Mechanism of CD38 via NAD + in the Development of Non-alcoholic Fatty Liver Disease
Min Dong, Shuo Wang, Zuowei Pei · 2023 · International Journal of Medical Sciences
Nicotinamide riboside and dietary restriction effects on gut microbiota and liver inflammatory and morphologic markers in cafeteria diet–induced obesity in rats
Larisse Longo, Josimar Macedo de Castro, Melina Belén Keingeski, Pabulo Henrique Rampelotto, Dirson João Stein, Gabriel Tayguara Silveira Guerreiro, Valessa Emanoele Gabriel de Souza, Carlos Thadeu Schmidt Cerski, Carolina Uribe Cruz, Iraci Lucena da Silva Torres et al. · 2023 · Nutrition
Design of new CD38 inhibitors based on CoMFA modelling and molecular docking analysis of 4‑amino-8-quinoline carboxamides and 2,4-diamino-8-quinazoline carboxamides
Bakhtyar Sepehri, Raouf Ghavami · 2018 · SAR and QSAR in environmental research
NAD+-Consuming Enzymes in Stem Cell Homeostasis
Xiuna Ji, Mingyue Zheng, Tao Yu, Jie Kang, Ting‐Jun Fan, Bin Xu · 2023 · Oxidative Medicine and Cellular Longevity
Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review
Xianghui Zhao, Peiying Lv, Zixing Cai, Jun Dong, Wenxiang Chen, Liang Sun, Ruiyue Yang · 2025 · Frontiers in Immunology
NAD+ glycohydrolases-CD38 as a therapeutic target in aging: physiological roles, molecular mechanisms, and future opportunities in anti-aging research
Jing-Yu Sun, Zhifei Wang, Wenhui Xu, Jun Zhao · 2025 · Biochemical Pharmacology
Regulating the regulators via targeting CD38 in the tumor microenvironment
Navnita Dutta, Nabanita Halder, Eduardo N. Chini, Sungjune Kim, Alak Manna · 2026 · Frontiers in Immunology
Functional identification of soluble uric acid as an endogenous inhibitor of CD38
Shijie Wen, Hiroshi Arakawa, Shigeru Yokoyama, Yoshiyuki Shirasaka, Haruhiro Higashida, Ikumi Tamai · 2024 · eLife
The Purinergic Landscape of Non-Small Cell Lung Cancer
Serena Janho dit Hreich, Jonathan Benzaquen, Paul M Hofman, Valérie Vouret‐Craviari · 2022 · Cancers
Role of Liver CD38 in the Regulation of Metabolic Pathways during Cold-Induced Thermogenesis in Mice
Andrea Benzi, Sonia Spinelli, Laura Sturla, Markus Heine, Alexander W. Fischer, Friedrich Koch‐Nolte, Hans‐Willi Mittrücker, Andreas H. Guse, Antonio DE FLORA, Jöerg Heeren et al. · 2022 · Cells
Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma
Catherine M. Mills, Thomas Zachary Benton, Ivett C. Piña, Megan J. Francis, Leticia Reyes, Nathan G. Dolloff, Yuri Karl Peterson, Patrick M. Woster · 2023 · Chemical Science
Characterization, Preclinical Efficacy and Toxicity Evaluations of Flavonoids Glycosides based Standardized Fenugreek Seed Extract (FEFLG)
Prasad Arvind Thakurdesai, Pallavi Deshpande, Mukul P Pore · 2023 · Pharmacognosy Journal
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials
Ye Wu, Xia Wu, Xiaoyan Liu, Xue Yan Zheng, Jili Deng, Yuping Gong · 2021 · BMC Cancer
Enzymatic and microenvironmental regulation in adenosine metabolism-mediated immunosuppression
Chuang Li, Lifeng Chen, Zhihao Li, Ling Liang, Benyong Lou · 2026 · Frontiers in Immunology
CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages
William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya N. M. Pandruvada, Yan Qin Huang, Özlem Yilmaz, Hong H. Yu · 2024 · Cells
CD38 deficiency promotes skeletal muscle and brown adipose tissue energy expenditure through activating NAD+-Sirt1-PGC1α signaling pathway
Qi Ding, Ke Wen, Qian Li, Qi‐Hang Zhao, Jia-Le Zhao, Yun‐Fei Xiao, Xiao‐Hui Guan, Meixiu Jiang, Feng Zhang, Ling-Fang Wang · 2023 · Canadian Journal of Physiology and Pharmacology
Targeting of CD38 and other NAD-dependent Enzymes in Leukemia Patients
Zainab Hillel, Zainab N. Al-Abady · 2023 · Journal of Biomedicine and Biochemistry
Snake venom NAD glycohydrolases: primary structures, genomic location, and gene structure
Ivan Koludarov, Steven Douglas Aird · 2019 · PeerJ
The omics based study for the role of superoxide dismutase 2 (SOD2) in keratinocytes: RNA sequencing, antibody-chip array and bioinformatics approaches
Hai-Long Li, Jae-Rin Lee, Myong‐Joon Hahn, Jun‐Mo Yang, Fanguo Meng, Jiawei Wu, Yong‐Doo Park · 2019 · Journal of Biomolecular Structure and Dynamics
Cardiomyocyte specific CD38 deletion protects heart from acute myocardial infarction by activating Sirt3 signaling pathway
Ke Wen, Yating Zhang, Qi‐Hang Zhao, Qian Li, Jia-Le Zhao, Qi Ding, Yun‐Fei Xiao, Xiao‐Hui Guan, Meixiu Jiang, Yisong Qian et al. · 2025 · Scientific Reports
CD38-NAD(+) Axis: New Insights into Glaucoma Therapy
Wenyige Zhang, Haina Zheng, Yulian Pang, Yujia Wang, Xu Zhang · 2025 · Molecular Neurobiology
Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-N1-inosine 5′-monophosphate, Analogues and Early Structure-Activity Relationship
Joanna M. Watt, Richard Milton Graeff, Barry V. L. Potter · 2021 · Molecules
Protein Acetylation and NAD+ Homeostasis in Aging Muscle
Li Li Ji · 2025 · Advances in experimental medicine and biology
A comprehensive analysis reveals the relationship between artificial sweeteners and prostate cancer
Kuiyuan Zhang, Bangwei Che, Pudong Gao, Wei Li · 2025 · Frontiers in Nutrition
MITA/STING-driven CD38 induction in Siglec-Flow macrophages promotes regulatory T cell survival and non-small cell lung cancer progression
Zhi-Dong Zhang, Yu-Lin Lin, Han-Yue Zhang, Cong Zuo, Zhong-Lin ZHU, Xing-Yuan Wang, Hao-Yu DUAN, Junjie Zhang, Dandan Lin, Bo Zhong · 2026 · Developmental Cell
Evolving understandings for the roles of CD38 protein in autoimmunity and autoimmune disease
Xiaochun Ye, Jieying Zhang, Mengping Song, Ping Wang, Irma Arés, Bernardo López-Torres, Marta Martínez, María‐Rosa Martínez‐Larrañaga, Jorge-Enrique Maximiliano, Arturo Anadón et al. · 2026 · Clinical & Experimental Immunology
Therapeutic Potential of ACMSD Inhibitors in NAD+ Deficient Diseases
Min Chen, Hua Zhang, Pengfei Ji · 2025 · Drugs and Drug Candidates
The Role of NAD+ in Anti-Aging Therapies
Xu-Qian Liu, Tao-Sheng Huang · 2019 · American Journal of Biomedical Science & Research
Profiling Glutathionylome in CD38-Mediated Epithelial–Mesenchymal Transition
Yingying Ma, Songbiao Zhu, Meiqi Yi, Wenhao Zhang, Yuanyuan Xue, Xiaohui Liu, Haiteng Deng · 2022 · Journal of Proteome Research
CD38 deficiency prevents diabetic nephropathy by inhibiting lipid accumulation and oxidative stress through activation of the SIRT3 pathway
Ling-Fang Wang, Qian Li, Jia Le Zhao, Ke Wen, Yating Zhang, Qi‐Hang Zhao, Qi Ding, Jiahui Li, Xiao‐Hui Guan, Yun‐Fei Xiao et al. · 2024 · Biochemistry and Cell Biology
Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials
Jasmeet Kaur, Paramveer Singh, Thomas Enzler, Vaibhav Sahai · 2021 · Expert Opinion on Emerging Drugs
Qualia NAD+® Increases NAD+ Levels In Human Participants: A Double-Blind, Placebo-Controlled Study
Sarah A. Blomquist, Gregory Kelly, Sara Adães, Christopher R. D’Adamo, Abhimanyu Ardagh, Shawn Ramer, William Scuba · 2025 · medRxiv
Rapid Discovery of CD38 Inhibitor via DNA-Encoded Natural Product Library Screening
Xinyu Shi, Ze Liang, Wentao Meng, Guang Yang, Lei Yan · 2026 · Molecules
Discovery of Potent and Orally Bioavailable Novel Cluster of Differentiation 38 (CD38) Small Molecule Inhibitors
Reza Shiroodi, Timothy J. Montavon, Brandon M. Nelson, John T. Randolph, Daniel E. O’Flynn, Leo Iu, Charles W. Hutchins, Tomas Baikstis, Javier Izquierdo, Don Smyth et al. · 2026 · Journal of Medicinal Chemistry
Dysfunction of the CD38-Miro1 Axis Disrupts Astrocyte-neuron Mitochondrial Transfer in Alzheimer’s Disease: Mechanisms and Therapeutic Restoration
Ahmed M Abdelaziz, Mustafa M Shokr, Mohamed K. Fathy, Mohamed N Fawzy · 2026 · Journal of Molecular Neuroscience
Bioenergetic impairment-induced Tau acetylation: Converging pathways in Alzheimer’s disease
Basavaraju K C, Poornima Priyadarshini C. G. · 2026 · International review of neurobiology
Cd38 A Biomarker and Therapeutic Target in Non-Hematopoietic Tumors
Susana G Barrientos-Robledo, Jorge Cebada, Juan Carlos Rodríguez‐Alba, Shantal Lizbeth Baltierra‐Uribe, María Alicia Díaz y Orea, Héctor Romero‐Ramírez · 2022 · Biomarkers in Medicine
CAR-T cell therapy for multiple myeloma: An update on the current state and future potential
Prateek A. Pophali, Jacalyn M. Rosenblatt, David Avigan · 2025 · Best Practice & Research Clinical Haematology
Oxidative stress-induced proinflammatory secretion from retinal pigment epithelium disrupts NAD+ metabolism via CD38 on macrophages leading to immune microenvironment dysregulation
Ruoyi Lin, Feng Liang, Chengyu Hu, Lei Jiang, Zhongqi Wan, Zihang Xu, Yunhong Luo, Jingyang Ma, Yan Wu, Wenting Cai et al. · 2025 · Free Radical Biology and Medicine
Novel Roles for the Ectoenzyme CD38 in the Maintenance of Transcriptional and Metabolic Homeostasis in Astrocytes
S. Basak, Alana M Colafrancesco, Raymundo D. Hernandez, Xiaoran Wei, Laura J. McMeekin, D. Dang, Megan Simmons, Jack L. Browning, K. Noel, Fuguo Zhou et al. · 2025 · Glia
CD38 promotes LPS-induced innate-like activation and proliferation of CD8+ T lymphocytes in aged mice
Wendolaine Santiago‐Cruz, Enrique Espinosa, Jocelyn C. Pérez-Lara, Héctor Romero‐Ramírez, Priyadharshini Devarajan, Fabio García‐García, Juan Carlos Rodríguez‐Alba · 2025 · Frontiers in Aging
Integrative meta-GWAS and lipidomics reveal genetic regulators of nutritional fatty acids and lipid metabolites in chicken liver lipid accumulation
Bingxing An, Na Luo, Peihao Liu, Limin Wei, Lingzhao Fang, Jie Wen, Guiping Zhao · 2026 · Journal of Agriculture and Food Research
Precision targeting of CD38 in immune thrombocytopenia: Mechanistic foundations and therapeutic implications
Xin Zhou, Yubao Liu, Peipei Zhang, Ningning Shan · 2026 · European Journal of Pharmacology
Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming
Preethi Gopalakrishnan Nair, B. S. Unnikrishnan, Vishnu Vijay Vijayan, Susan E. Howlett, Pieter R. Cullis, Shashi Ashok Gujar · 2026 · ACS Nano
Apigenin Protects Against Cisplatin-Induced Cardiotoxicity: Potential Involvement of CD38-Sirt3 Signaling in Rats
Natticha Sumneang, Jannarong Intakhad, Worakan Boonhoh, Arnon Pudgerd, Orawan Wongmekiat, Anongporn Kobroob · 2026 · Molecules
Effect of acipimox on skeletal muscle biochemistry, structure and function in older people with probable sarcopenia: an experimental medicine study
Claire McDonald, Craig Alderson, Matthew G. Birkbeck, Silvia Del Din, Gráinne S. Gorman, Kieren G. Hollingsworth, Cameron Kirk, Clare Massarella, Lynn Rochester, Helen A. L. Tuppen et al. · 2025 · GeroScience
Elucidation of the cell signaling pathways mediating innate immunity and host-pathogen interactions
Neel R. Nabar · 2019 · Figshare
PRMT5 regulates the NAD-SIRT1-p53 signal axis by affecting the methylation of CD38 at R58 to promote malignant tumor cell proliferation
Yanhong Zhou, Lin Liang, Chunxue Yue, Wentao Li, Mengxiang Gao, Feng Zeng, Junyu He, Zhengxi He, Xi Jin, Qianjin Liao et al. · 2022 · Research Square
Peer Review #2 of "Snake venom NAD glycohydrolases: primary structures, genomic location, and gene structure (v0.1)"
2019 · PeerJ
Peer Review #2 of "Snake venom NAD glycohydrolases: primary structures, genomic location, and gene structure (v0.2)"
2019 · PeerJ
Comparison of Monoclonal Antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus Dexamethasone/Prednisone for the treatment of Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials
Ye Wu, Xia Wu, Xiaoyan Liu, Xue Li Zheng, Jili Deng, Yuping Gong · 2020 · Research Square